搜索

购物车()
首页> 生物试剂
SF7761 Human DIPG H3.3-K27M Cell Line
  • 商城价格 登录后可查看价格
  • 货号 SCC126
  • 品牌 Merck millipore/默克密理博 ( 一级代理 )
  • CAS号 见包装
  • 规格/包装 200UNITS
  • 单位
  • 储存条件 见包装
  • 现货状态 询货

  • 数量

    - +

    成功收藏产品
  • 立即购买
商家描述 售后服务 商家资质信息 产品评价(0)
Diffuse intrinsic pontine gliomas (DIPG) are highly aggressive and difficult to treat tumors arising in the ventral pons of the brain stem. Despite therapeutic advances, DIPG is incurable and most patients, primarily children, die within 2 years of diagnosis. DIPG is one of the leading causes of death in children with brain tumors .A somatic mutation of histone H3.3 resulting in a lysine 27 to methionine substitution (H3.3K27M) occurs in 60% of DIPG . In H3.3K27M DIPG patient samples, levels of H3K27 dimethylation (H3K27me2) and trimethylation (H3K27me3) are reduced globally. Expression of H3.3K27M was also shown to be associated with increased levels of H3K27 acetylation (H3K27ac) and recruitment of bromodomain proteins at sites of active transcription . These epigenetic changes are thought to be important factors driving DIPG oncogenesis ,官网链接:https://www.sigmaaldrich.cn/product/mm/scc126m 默克 科研、开发、生产。 作为生命科学行业的全球领先供应商,我们致力于为科研、生物技术开发和生产,以及制药药物疗法开发和生产提供各类解决方案和服务。
返回顶部